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Abstract: Hepatic glutathione synthesis and antioxidant protection are critically important for
efficient detoxification processes in response to metabolic challenges. However, this biosynthetic
pathway, regulated by nuclear factor (erythroid-derived 2)-like 2 (Nrf2), previously demonstrated
paradoxical repression following exposure to glucocorticoid stress hormones in cultured hepatic
cells. Therefore, the present study used an in vivo model of sub-acute psychological stress to
investigate the relationship between hepatic corticosteroid regulation and antioxidant systems.
Male Wistar rats were kept under control conditions or subjected to six hours of restraint stress
applied for 1 or 3 days (n = 8 per group) after which the liver was isolated for assays of
oxidative/nitrosative status and expression of corticosteroid regulatory and Nrf2-antioxidant response
element pathway members. A single stress exposure produced a significant increase in the expression
of corticosterone reactivator, 11-beta-hydroxysteroid dehydrogenase 1 (11β-Hsd1), while the 11β-Hsd2
isozyme and corticosteroid-binding globulin were down-regulated following stress, indicative of an
elevated availability of active corticosterone. Exposure to restraint significantly decreased hepatic
concentrations of total cysteine thiols and the antioxidant reduced glutathione on Day 1 and increased
3-nitrotyrosinated and carbonylated proteins on Day 3, suggestive of oxidative/nitrosative stress in
the liver following stress exposure. Conversely, there was a sustained down-regulation of Nrf2 mRNA
and protein in addition to significant reductions in downstream glutamate-cysteine ligase catalytic
subunit (Gclc), the rate-limiting enzyme in glutathione synthesis, on Day 1 and 3 of stress treatment.
Interestingly, other antioxidant genes including superoxide dismutase 1 and 2, and glutathione
peroxidase 4 were significantly up-regulated following an episode of restraint stress. In conclusion,
the results of the present study indicate that increased expression of 11β-Hsd1, indicative of elevated
tissue glucocorticoid concentrations, may impair the Nrf2-dependent antioxidant response.
Keywords: antioxidant response; corticosteroids; liver; Nrf2; oxidative stress
1. Introduction
Glucocorticoids (cortisol and corticosterone) are the main effector hormones of the
hypothalamic-pituitary-adrenal (HPA) axis and their levels dynamically increase with exposure
to physiological and psychological stressors. Termination of the stress response is mediated by
glucocorticoids via negative feedback to the anterior pituitary, hypothalamus, and extra-hypothalamic
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centers which reduces HPA axis flux to restore homeostasis [1,2]. According to the free hormone
hypothesis, this feedback is mediated by the unbound, physiologically active glucocorticoids that are
able to cross the blood-brain barrier and bind glucocorticoid receptors [3]. It was estimated that about
5% of glucocorticoids circulate freely, while 80–90% bind to corticosteroid-binding globulin (CBG;
formally transcortin), and 5–10% bind non-specifically to albumin in the bloodstream [4,5]. Previous
reports demonstrated that CBG, produced primarily in the liver, plays an important role in regulation
of the stress response, with reductions in CBG expression transiently increasing free glucocorticoid
bioavailability [6–9]. The action of glucocorticoids on target tissues is mediated by glucocorticoid (GR)
and mineralocorticoid (MR) receptors which exert canonical nuclear hormone receptor effects and rapid
non-genomic membrane-associated activity [10]. In addition to circulating concentrations, local tissue
levels of glucocorticoids can be modulated by two isozymes of 11β-hydroxysteroid dehydrogenase
(11β-HSD) [11]. The type one 11β-HSD (11β-Hsd1) isozyme predominantly possesses reductase activity
and catalyzes the NADPH-dependent conversion of inert cortisone and 11-dehydrocorticosterone to
active cortisol and corticosterone, respectively [12]. We previously showed that an up-regulation of
11β-Hsd1 expression in extra-hypothalamic regions may facilitate negative feedback suppression of
the HPA axis following acute stress [13]. The second isozyme (11β-Hsd2) requires NAD+ as co-factor
and exclusively possesses dehydrogenase activity which acts to rapidly inactivate glucocorticoids
by converting cortisol/corticosterone back to their respective keto-forms [14]. A critical role of
11β-Hsd2 is to protect the MR from promiscuous activation by promoting glucocorticoid metabolism,
thereby safeguarding the activity of aldosterone as the principal physiological agonist of MR in
aldosterone-sensitive regions [15,16].
Several animal studies reported substantial hepatocellular damage in the form of elevated
liver enzymes following acute and chronic stress [17–20]. This is often accompanied by increased
markers of oxidative stress, including increased oxidized glutathione (GSSG), lipid peroxidation,
nitrite and nitrate (NOx), and myeloperoxidase activity in the liver following stress [17,19,21].
This stress-induced imbalance in reduction/oxidation (redox) state is simultaneously observed with
decreased antioxidant components including reduced glutathione (GSH), superoxide dismutase (SOD),
catalase, and ascorbic acid [21,22]. A major mechanism in the cellular defense against oxidative stress is
activation of nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf2). Following nuclear translocation,
activated Nrf2 binds to antioxidant response elements (ARE) to regulate phase II detoxifying enzymes
such as glutamate-cysteine ligase, glutathione peroxidase (GPx), heme oxygenase 1 (Hmox1), and
quinone oxidoreductase 1 (Nqo1) [23]. Studies using Nrf2 knockout mice demonstrated substantial
susceptibility to a broad range of chemical toxicities and disease conditions associated with oxidative
pathology [24–26]. Interestingly, work by Kratschmar and colleagues [27] showed that hepatic Nrf2 is
suppressed in response to increased activity of 11β-Hsd1 in vitro. However, the relationship between
hepatic corticosteroid regulation and antioxidant systems following psychological stress in vivo has
not been well characterized. The present study used an in vivo model of sub-acute psychological
stress to investigate the relationship between hepatic corticosteroid regulation and antioxidant systems
following stress exposure.
2. Materials and Methods
2.1. Animals
Ethics approval was obtained from the University of Queensland Animal Ethics Committee under
approval number SBS/456/14/URG. Male Wistar rats (298.3 ± 4.1 g) aged 7–8 weeks were bred and
sourced from The University of Queensland Biological Resources and housed in groups of four within
the Australian Institute of Biotechnology and Nanotechnology animal facility. Rats were housed in a
colony room with controlled temperature (22 ± 2 ◦C) and humidity; (55 ± 5%) on a 12-h light-dark
cycle (lights on at 07.00 h) with food and water provided ad libitum. Rats were habituated to handling
for 10 min per day over six consecutive days prior to experimentation.
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2.2. Experimental Protocol
Rats were randomly allocated into treatment groups of no stress (unstressed; US), acute (1 Day,
single episode of 6 h), or repeated restraint stress (3 Days, 6 h per day) from 9.00 h to 15.00 h using
adjustable wire mesh restrainers (n = 8 per group). Rats were transported on each treatment day
to an experimental room within the same animal facility and were acclimated for 1 h prior to any
experimental procedures. At the end of the treatment, rats were immediately anesthetized with
Pentobarbital Sodium (100 mg/kg, intraperitoneal injection; Lethabarb, Virbac) and whole blood
samples were collected via cardiac puncture into ice-chilled tube containing heparin (20 IU/mL blood).
Blood samples were centrifuged at 2000× g and the resultant plasma was collected and stored at −80 ◦C
for measurement of total corticosterone levels. Liver tissues were quickly snap-frozen for later relative
mRNA expression, biochemical, Western blotting, and immunofluorescence analysis.
2.3. Plasma Corticosterone Measurements
Total plasma corticosterone concentrations were determined using DetectX® Corticosterone
Enzyme Immunoassay Kit (Cat. No. K014-H1; Arbor AssaysTM, Ann Arbor, MI, USA) according to the
manufacturers’ instructions.
2.4. mRNA Expression
For the analysis of gene expression, total RNA was isolated from liver tissues using the RNeasy
mini kit (QIAGEN, Doncaster, Australia) and further purified with deoxyribonuclease 1 treatment
(QIAGEN) according to the supplier’s protocol. Extracted RNA concentrations and purity were
measured using the Nanodrop 2000c spectrophotometer and Agilent 2100 Bioanalyzer respectively.
Agilent RNA 6000 Nano Kits were used to determine the RNA integrity values, with an average
RIN = 9.23 for all samples analyzed. Subsequently, 2 µg of RNA was reverse transcribed into cDNA
using the iScriptTM reverse transcription supermix, including controls omitting the reverse transcriptase
(Bio-Rad Laboratories, Gladesville, Australia). The cDNA was amplified using gene specific TaqManTM
Gene Expression Assays (Applied Biosystems, Foster City, CA, USA) for the genes listed in Table 1.
No amplification was observed in the template omission or reverse transcriptase omission controls.
Target gene expression was determined relative to a primer-limited and well-characterized VIC-labeled
β-actin (Actb; Applied Biosystems) using the formula 2-∆Ct where ∆Ct = (Ct target gene − Ct ACTB)
and expressed relative to unstressed controls. No changes were observed in target gene amplification
efficiency using this multiplex reaction system.
Table 1. List of TaqmanTM gene expression assays used for quantification of mRNA levels.
Gene Symbol Gene Name RefSeq AccessionNumber
Assay ID (in Applied
Biosystems)
Brd4 Bromodomain-containing protein 4 NM_001100903.1 Rn01535560_m1
Cat Catalase NM_012520.2 Rn00560930_m1
Foxo1 Forkhead box O1 NM_001191846.2 Rn01494868_m1
Gclc Glutamate-cysteine ligase, catalytic NM_012815.2 Rn00689046_m1
Gpx1 Glutathione peroxidase 1 NM_030826.3 Rn00577994_g1
Gpx4 Glutathione peroxidase 4 NM_001039849.2 Rn00820818_g1
Hmox1 Heme oxygenase 1 NM_012580.2 Rn00561387_m1
Hsd11b1 Hydroxysteroid 11-beta dehydrogenase 1 NM_017080.2 Rn00567167_m1
Hsd11b2 Hydroxysteroid 11-beta dehydrogenase 2 NM_017081.2 Rn04341420_g1
Keap1 Kelch-like ECH-associated protein 1 NM_057152.2 Rn01448220_m1
Nfe2l1(Nrf1) Nuclear factor, erythroid 2-like 1 XM_006247236.2 Rn01452824_m1
Nfe2l2(Nrf2) Nuclear factor, erythroid 2-like 2 NM_031789.2 Rn00582415_m1
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Table 1. Cont.
Gene Symbol Gene Name RefSeq AccessionNumber
Assay ID (in Applied
Biosystems)
Nqo1 NAD(P)H dehydrogenase, quinone 1 NM_017000.3 Rn00566528_m1
Nos2 Nitric oxide synthase 2, inducible NM_012611.3 Rn00561646_m1
Nos3 Nitric oxide synthase 3, endothelial NM_021838.2 Rn02132634_s1
Nr3c1 Nuclear receptor subfamily 3, group C,member 1 NM_012576.2 Rn00561369_m1
Serpina6(Cbg) Serpin peptidase inhibitor, clade A (alpha-1antiproteinase, antitrypsin), member 6 NM_001009663.1 Rn01517119_m1
Sod1 Superoxide dismutase 1, soluble NM_017050.1 Rn00566938_m1
Sod2 Superoxide dismutase 2, mitochondrial NM_017051.2 Rn00690588_g1
2.5. Preparation of Liver Tissue for Biochemical Assays
Biochemical assays of oxidative and nitrosative status were performed in isolated liver tissues
homogenized (IKA® Ultra-Turrax® T10) in 7.5 volumes (w/v) of Tris-HCl (0.05 M, pH = 7.4) containing
a cocktail of protease inhibitors (Cat no S8830, Sigma-Aldrich, Castle Hill, Australia). An aliquot of
liver crude homogenate was removed for GSH and GSSG determination. This aliquot was loaded
with an acidic solution containing 10% trichloroacetic acid (w/v) in 0.1 M potassium phosphate buffer
containing 5 mM EDTA (KPE buffer; pH = 7.5) and left on ice for 5 min prior to centrifugation at
10,000× g for 5 min to prevent the oxidation of reduced GSH. The remaining crude homogenate was
centrifuged at 10,000× g for 10 min at 4 ◦C and the supernatant was used for the determination of free
cysteine thiols, general oxidative status, protein carbonylation, lipid peroxidation, and 3-nitrotyrosine
with corresponding protein concentrations.
2.6. Reduced and Oxidized Glutathione
Reduced GSH and GSSG concentrations were determined as described previously by our
group [13] with slight modifications. Liver homogenates deproteinated with trichloroacetic acid
were further treated with or without N-ethylmaleimide and redox quenched samples were loaded
with the fluorophore O-phthaldialdehyde (OPA). Samples were incubated for 30 min in the dark
and fluorescence was determined using a POLARstar OPTIMA (BMG Labtechnologies, Offenburg,
Germany) with excitation and emission filters set at 365 nm and 430 nm, respectively. GSH and GSSG
levels were subsequently adjusted to corresponding total protein concentrations, and expressed as
percentage change relative to unstressed values.
2.7. Free Thiol Detection
The Thiol Detection Assay Kit (Cat no: 700340, Cayman Chemical, Ann Arbor, MI, USA) was
used to determine liver free thiol content according to the manufacturer’s instructions and presented
as nM per mg protein.
2.8. General Oxidative Status
General oxidative status was determined in liver samples as described in our previous work [28]
with slight modifications. A working solution of 100 µM 2′,7′-dichlorofluorescein diacetate (DCFH-DA)
was prepared in 0.05 M of Tris-HCl. Diluted supernatant of liver homogenate was loaded with 50 µL
of 100 µM DCFH-DA and incubated for 30 min at 37 ◦C. Sample fluorescence was measured by
POLARstar® OPTIMA microplate reader (BMG Labtechnologies) with excitation and emission filters
set at 485 nm and 520 nm respectively. Data was normalized with corresponding protein concentrations
and expressed as arbitrary fluorescence units (AU) per mg protein.
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2.9. Lipid Peroxidation
The peroxidation of lipid in hepatic tissue was determined using a thiobarbituric acid-reactive-
substances (TBARS) assay as described in our previous work [29]. The reacted malondialdehyde
(MDA)-thiobarbituric (TBA) adduct in the supernatant of liver homogenate was extracted with
n-butanol and measured fluorometrically at 544 nm (excitation) and 590 nm (emission) using the
POLARstar OPTIMA microplate reader. Sample values were quantified from a standard curve using
1,1,3,3-tetraethoxypropane as an external standard, corrected for corresponding protein concentrations,
and expressed as nM per mg of protein.
2.10. Protein Carbonyl
Protein-bound carbonyls were determined via a protein carbonyl assay kit (Cat no: 10005020,
Cayman Chemical). The assay uses the covalent reaction of 2,4-dinitrophenylhydrazine with the
carbonylated protein side chain and the amount of protein–hydrazone produced is quantified
spectrophotometrically at 370 nm. The results were calculated using the extinction coefficient
of 22 mM−1cm−1 for aliphatic hydrazones, corrected for corresponding protein concentrations, and
expressed as nmol per mg protein.
2.11. 3-Nitrotyrosine
Quantification of 3-nitrotyrosine modified proteins in liver supernatant was performed using
a commercially available ELISA kit (Cat no: ab116691, Abcam, Cambridge, MA, USA). Unknown
concentrations were determined from 3-NT bovine serum albumin standard equivalents, corrected for
corresponding protein concentrations, and expressed as ng per mg protein.
2.12. Immunofluorescence
Snap-frozen liver tissues were cut into 12 µm sections, mounted, washed three times
in phosphate-buffered saline, and subsequently fixed for 15 min with phosphate-buffered
paraformaldehyde (4%, w/v). Citrate antigen retrieval was performed for 20 min at 95 ◦C prior
to blocking in normal goat serum and overnight incubation with primary antibodies against Sod1 (1:200
dilution; Cat no: ADI-SOD-100-D, Enzo Life Sciences, Plymouth Meeting, PA), 4-hydroxy-2-nonenal
(4-HNE; 1:200 dilution; Cat no: ab46545, Abcam), and Nrf2 (1:50 dilution; Cat no: NBP1-32822, Novus
Biologicals, Littleton, CO, USA) at 4 ◦C. Secondary antibodies (1:500 dilution; Alexa FluorTM 488
goat anti-rabbit, Invitrogen, Mt Waverley, VIC, Australia) were subsequently applied and sections
were counterstained with Hoechst 33342 (1:2000 dilution; ThermoFisher Scientific, San Diego, CA,
USA). Sections were imaged at 20× magnification and at 63× for NRF2 nuclear localization under
confocal microscopy (Zeiss LSM 780) and ImageJ was used for further analysis of Sod1, 4-HNE,
and Nrf2 immunofluorescence.
2.13. Western Blotting
Liver tissues were prepared and lyzed using a buffer containing 20 mM Tris (pH 7.5), 1% Triton
X-100 (v/v), and protease inhibitors. The protein concentration of each sample was determined by the
bicinchoninic acid method and equal amounts of protein (20 µg) were separated by electrophoresis on
Bolt™ 4 to 12% Mini Protein Gels (ThermoFisher). After electrophoresis, the proteins were transferred
to polyvinylidene difluoride membranes, followed by nonspecific blocking (5% w/v skimmed milk in
phosphate-buffered saline with 0.05% v/v Tween® 20) for 1 h at room temperature. The membranes
were then incubated with primary antibodies against Sod1 (1:1000 dilution; Cat no: ADI-SOD-100-D,
Enzo Life Sciences) and Nrf2 (1:500 dilution; Cat no: NBP1-32822, Novus Biologicals) overnight
at 4 ◦C. After 4–5 washes, the membranes were treated with the appropriate secondary antibodies
(1:15,000 dilution; IRDye® 680RD and IRDye® 800CW Infrared Dyes, Li-Cor, Lincoln, NE) for 1 h.
β-actin (1:3000 dilution; Cat no: ab6276, Abcam) was used as the internal loading control for all of the
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Western blotting experiments. The blots were visualized using the Odyssey® CLx Infrared Imaging
System (Li-Cor).
2.14. Protein Determination
Protein was determined using commercially available Red660TM protein kit (G-Biosciences,
St. Louis, MO, USA) using bovine serum albumin as a standard.
2.15. Statistical Analyses
All data were expressed as mean ± standard error of the mean (±SEM). Statistical comparisons
were performed using GraphPad Prism (Version 8.0.1, GraphPad Software Inc., San Diego, CA, USA)
with p ≤ 0.05 considered to be statistically significant. Data were first analyzed for normality using the
Brown-Forsythe test. One-way ANOVA with Fisher’s least significant difference (LSD) test was used
to compare normally distributed data. Non-parametric Kruskal-Wallis ANOVA with Dunn’s multiple
comparisons test was used for data sets with significantly different standard deviations.
3. Results
3.1. Restraint Stress-Induced Corticosterone Was Accompanied by Altered Hepatic Expression of Glucocorticoid
Bioavailability Mediators
Restraint stress significantly increased plasma corticosterone above values of unstressed controls
following a single episode (p < 0.05) and repeated restraint stress (p < 0.01) exposure (Figure 1A).
The availability of GR governs subsequent corticosteroid responsiveness, and in the present study,
mRNA expression of GR (Nr3c1) in the liver was significantly down-regulated following 3 days
(p < 0.01) of repeated stress (Figure 1B). The negative acute phase protein, CBG, is synthesized and
secreted by the liver to modulate tissue availability of glucocorticoids. In the present study, stress
treatment significantly down-regulated hepatic expression of CBG (Serpina6) following 3 days (p < 0.05)
of repeated restraint (Figure 1C). The 11β-Hsd1 enzyme converts inactive glucocorticoids into active
corticosterone, and stress significantly increased Hsd11b1 mRNA levels following 1 day (p < 0.01)
of stress relative to unstressed controls (Figure 1D). Concurrently, Hsd11b2 mRNA expression was
significantly down-regulated following both day 1 and 3 (p < 0.05) of stress treatment (Figure 1E).
Together, increased 11β-Hsd1 and decreased 11β-Hsd2 expression indicates an increased capacity for
regeneration of active glucocorticoids locally in hepatic tissue.
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11-beta dehydrogenase 1 (Hsd11b1), and (E) hydroxysteroid 11-beta dehydrogenase 2 (Hsd11b2)
compared to unstressed (US) rats (n = 6–8/group). Results in (C,E) were analyzed using one-way
ANOVA with Fisher’s LSD test; (A,B,D) were analyzed using non-parametric Kruskal-Wallis test with
Dunn’s post-test. Data are expressed as mean ± SEM, * p < 0.05 and ** p < 0.01.
3.2. Restraint Stress-Induced Hepatic Oxidative and Nitrosative Imbalance and Oxidative Damage
In the present study, we used established biochemical and molecular indicators to demonstrate
the profile of redox changes within the liver following acute and repeated restraint stress. Free thiols
are essential antioxidant mediators with the capacity to maintain redox homeostasis and include
thiol/disulfide redox couples such as 2GSH/GSSG, thioredoxins, and other cysteine-containing proteins.
As shown in Figure 2A, free cysteine thiol content in the liver was significantly reduced following 1
(p < 0.01) and 3 (p < 0.001) days of restraint stress. Moreover, stress exposure significantly reduced
levels of hepatic GSH (Figure 2B) and increased levels of hepatic GSSG (Figure 2C). Together, these
results suggest that acute and repeated stress induces a pro-oxidative state through a loss in GSH/GSSG
redox balance in the liver.
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Figure 2. Restraint stress induces hepatic redox imbalance as shown by (A) decreased free cysteine
thiol content and (B) decreased reduced glutathione (GSH) with increased (C) glutathione disulfide
(GSSG). This occurs alongside increased mRNA expression of (D) superoxide dismutase 1 (Sod1)
and (E) superoxide dismutase 2 (Sod2) but decreased (F) catalase (Cat) compared to unstressed (US)
rats (n = 7–8/group). Results in (A–C,F) were analyzed using one-way ANOVA with Fisher’s LSD
test; (D,E) were analyzed using non-parametric Kruskal-Wallis test with Dunn’s post-test. Data are
expressed as mean ± SEM, ** p < 0.01, *** p < 0.001.
Superoxide dismutase, a key cellular antioxidant, acts to enzymatically eliminate superoxide
radicals (O2−). The mRNA expression of copper-zinc superoxide dismutase (Sod1; Cu, Zn-SOD) and
manganese-dependent superoxide dismutase (Sod2; Mn-SOD) were both up-regulated in the liver
following 1 day (p < 0.01) of stress (Figure 2D,E). As shown in Figure 3A,B there was also a significant
increase in Sod1 signal within the liver following 3 days (p < 0.01) of restraint stress. A similar
protein expression pattern of Sod1 was demonstrated by Western blot (a representative blot is shown
in Figure 3C). Even though the antioxidant activity of catalase was suggested to be highest in the
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liver to eliminate H2O2, we observed a significant down-regulation of liver catalase (Cat) mRNA
expression following 3 days (p < 0.01) of repeated restraint stress when compared to unstressed controls
(Figure 2F).Antioxidants 2020, 9, x FOR PEER REVIEW 8 of 20 
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were analyzed using one-way ANOVA with Fisher’s LSD test. Data are expressed as mean ± SEM,
** p < 0.01.
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The effects of stress on the general oxidative status in the liver was determined using DCFH-DA.
The oxidation of H2DCF to DCF was highest following 1 day (p < 0.01) of acute stress (Figure 4A).
Stress was also highly effective at increasing hepatic peroxidation of lipids following both acute
(p < 0.01) and repeated (p < 0.05) stress (Figure 4B). Furthermore, we found a significant increase in
immunoreactivity for 4-HNE, a major cytotoxic end product of lipid peroxidation, following 1 (p < 0.01)
and 3 (p < 0.001) days of restraint stress in the liver (Figure 5A,B). Protein carbonylation represents an
irreversible post-translational modification formed during oxidative stress conditions. We found that
stress significantly increased hepatic carbonylated proteins following 3 days (p < 0.001) of repeated
stress (Figure 4C).
We further found that the level of 3-nitrotyrosine was significantly increased in the liver following
3 days (p < 0.01) of repeated restraint stress (Figure 4D). Peroxynitrite forms through the reaction of
nitric oxide (NO) with O2−; and expression of both NO-catalyzing enzymes abundantly present in the
liver, inducible (Nos2; p < 0.01) and endothelial (Nos3; p < 0.05) nitric oxide synthase, was up-regulated
following 1 day of stress exposure (Figure 4E,F).
Antioxidants 2020, 9, x FOR PEER REVIEW 9 of 20 
The effects of stress on the general oxidative status in the liver was determined using DCFH-
DA. The oxidation of H2DCF to DCF was highest following 1 day (p < 0.01) of acute stress (Figure 
4A). Stress was also highly effective at increasing hepatic peroxidation of lipids following both acute 
(p < 0.01) and repeated (p < 0.05) stress (Figure 4B). Furthermore, we found a significant increase in 
immunoreactivity for 4-HNE, a major cytotoxic end product of lipid peroxidation, following 1 (p < 
0.01) and 3 (p < 0.001) days of restraint stress in the liver (Figure 5A,B). Protein carbonylation 
represents an irreversible post-translational modification formed during oxidative stress conditions. 
We found that stress significantly increased hepatic carbonylated proteins following 3 days (p < 0.001) 
of repeated stress (Figure 4C). 
We further found that the level of 3-nitrotyrosine was significantly increased in the liver 
following 3 days (p < 0.01) of repeated restraint stress (Figure 4D). Peroxynitrite forms through the 
reaction of nitric oxide (NO) with O2−; and expression of both NO-catalyzing enzymes abundantly 
present in the liver, inducible (Nos2; p < 0.01) and endothelial (Nos3; p < 0.05) nitric oxide synthase, 
was up-regulated following 1 day of stress exposure (Figure 4E,F). 
 
Figure 4. Restraint stress increases hepatic oxidative/nitrosative stress indicated by (A) 
dichlorofluorescein (DCF) formation, (B) malondialdehyde-thiobarbituric acid (MDA-TBA) adduct, 
(C) protein carbonyl, (D) 3-nitrotyrosine, and both (E) nitric oxide synthase 2, inducible (Nos2), and 
(F) nitric oxide synthase 3, endothelial cell (Nos3) expression compared to unstressed (US) rats (n = 7–
8/group). Results in (A,C,F) were analyzed using one-way ANOVA with Fisher’s LSD test; (B,D,E) 
were analyzed using non-parametric Kruskal-Wallis test with Dunn’s post-test. Data are expressed as 
mean ± SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. 
Figure 4. Restraint stress increases hepatic oxidative/nitrosative stress indicated by (A)
dichlorofluorescein ( CF) for ation, (B) malondialdehyde-thiobarbituric acid (MDA-TBA) adduct, (C)
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3.3. Nrf2 Was Robustly Down-regulated Following Short-Term Stress in the Liver
Despite a pro-oxidative state following stress, expression of Nrf2 (Nfe2l2), the master regulator of
an array of detoxifying and antioxidant defense genes, was strongly down-regulated following both
stress time-points (p < 0.001) in the liver (Figure 6A). Down-regulation of Nrf2 protein expression
following 3 days of stress was further demonstrated using immunoblotting (Figure 6B) and confirmed
by immunofluorescence analysis of nuclear localization and whole tissue sections (Figure 7A–C).
Analogous to Nrf2, nuclear factor erythroid-2–related factor 1 (Nrf1; Nfe2l1) is also known to be essential
for maintaining redox homeostasis and coordinating cellular stress responses. The expression of Nfe2l1
in the liver was transiently up-regulated following a single episode of stress (Figure 6C). Some of
the classical Nrf2 target genes involved in antioxidant defense include enzymes responsible for GSH
synthesis (Gclc, glutamate-cysteine ligase catalytic subunit, and glutathione synthetase) and reduction
of hydrogen peroxide (GPx family of enzymes). We found that expression of Gclc, the rate-limiting
enzyme responsible for GSH production, was significantly reduced in the liver following 1 (p < 0.01)
and 3 (p < 0.001) days of restraint stress when compared to unstressed controls (Figure 6D). Furthermore,
glutathione peroxide 4 (Gpx4) was significantly up-regulated following one (p < 0.01) episode of
stress exposure (Figure 6E). Interestingly, hepatic expression of Kelch-like ECH-associated protein 1
(Keap1), the specific repressor responsible for Nrf2 sequestration in the cytoplasm, was down-regulated
following 3 days (p < 0.05) of stress (Figure 6F).
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3.4. Phase II Detoxifying Enzymes Including Hmox1 and Nqo1 Were Up-regulated Following Restraint Stress
One of the most extensively studied phase II detoxifying/antioxidant enzymes, Hmox1, is an
essential enzyme in heme catabolism, cleaving heme to release carbon monoxide, ferrous iron (Fe2+),
and biliverdin. Following both 1 (p < 0.01) and 3 (p < 0.05) days of stress treatment, the mRNA
expression of Hmox1 was up-regulated in the liver (Figure 8A). Similarly, another Nrf2 target gene,
Nqo1, was up-regulated following both 1 day (p < 0.01) and 3 days (p < 0.05) of stress relative to
unstressed controls (Figure 8B). Figure 8C shows a significant up-regulation in Forkhead box protein
O1 (Foxo1) mRNA expression, an alternative mediator of the Keap1/Nrf2/ARE pathway, following 3
days (p < 0.05) of repeated stress exposure. Finally, the mRNA expression of the epigenetic sensor,
bromodomain-containing protein 4 (Brd4), known to regulate the Nrf2/Keap1 axis, showed a minor,
albeit significant, up-regulation following 1 day (p < 0.01) of restraint stress (Figure 8D).
Antioxidants 2020, 9, x FOR PEER REVIEW 13 of 20 
3.4. Phase II Detoxifying Enzymes Including Hmox1 and Nqo1 Were Up-regulated Following Restraint 
Stress 
e f t  t t i l  t i   II t if i / ti i t es, ox1, is  
esse tial  i   t li , l i    l   i ,  i  2+), 
a  ili r i . Following both 1 (p < 0.01) and 3 (p < 0.05) days of stress treat ent, the  
ex ression of ox1 as up-regulated in the liver (Figure 8A). Similarly, another rf2 target gene, 
qo1, as -re lated follo ing both 1 a  (   0.01) and 3 a s (   0.05) of stress r lative t  
str  tr l  ( i  ). i r   s s a sig ific t -r l ti  i  r ea  b x r tei  
1 ( oxo1)  ex ression, an alternative ediator of the eap1/ rf2/ E path ay, f ll i   
a s (   0.05) of repeated stress exposure. Finally, the RNA expres ion of the epigenetic sensor, 
r o ain-containing protein 4 (Brd4), known to regulate the Nrf2/Keap1 axis, showed a minor, 
al it si ifi t, -       0.01) of restrai t str  ( i  . 
 
Figure 8. Restraint stress increases expression of Phase II detoxifying enzymes and alternative redox 
modulators including (A) heme oxygenase 1 (Hmox1), (B) NAD(P)H dehydrogenase, quinone 1 
(Nqo1), (C) forkhead box O1 (Foxo1), and (D) bromodomain-containing protein 4 (Brd4) mRNA 
expression compared to unstressed (US) rats (n = 7–8/group). Results in (A,B) were analyzed using 
one-way ANOVA with Fisher’s LSD test; (C,D) were analyzed using non-parametric Kruskal-Wallis 
test with Dunn’s post-test. Data are expressed as mean ± SEM, * p < 0.05 and ** p < 0.01. 
4. Discussion 
The present study used a model of acute repeated restraint stress to investigate the relationship 
between high levels of glucocorticoids, redox balance, and the Nrf2-dependent and independent 
antioxidant responses in the liver. We showed that stress modulates local mediators of glucocorticoid 
bioavailability, including CBG and 11β-HSDs, reduces cellular antioxidant defense capacity likely via 
suppression of Nrf2-mediated GSH production, and induces an overall hepatic oxidative and 
nitrosative stress. This is in agreement with previous study by Kratschmar and colleagues [27], using 
cultured hepatic cells, which demonstrated that Nrf2 expression shared an inverse relationship with 
11β-Hsd1, with an increase in the latter resulting in an impaired cellular oxidant neutralization 
response. 
Figure 8. Restraint stress increases expression of Phase II detoxifying enzymes and alternative redox
modulators including (A) heme oxygenase 1 (Hmox1), (B) NAD(P)H dehydrogenase, quinone 1 (Nqo1),
(C) forkhead box O1 (Foxo1), and (D) bromodomain-containing protein 4 (Brd4) mRNA expression
compared to unstressed (US) rats (n = 7–8/group). Results in (A,B) were analyzed using one-way
ANOVA with Fisher’s LSD test; (C,D) were analyzed using non-parametric Kruskal-Wallis test with
Dunn’s post-test. Data are expressed as mean ± SEM, * p < 0.05 and ** p < 0.01.
4. Discussion
The present study used a model of acute repeated restraint stress to investigate the relationship
between high levels of glucocorticoids, redox balance, and the Nrf2-dependent and independent
antioxidant responses in the liver. We showed that stress modulates local mediators of glucocorticoid
bioavailability, including CBG and 11β-HSDs, reduces cellular antioxidant defense capacity likely via
suppression of Nrf2-mediated GSH production, and induces an overall hepatic oxidative and nitrosative
stress. This is in agreement with previous study by Kratschmar and colleagues [27], using cultured
hepatic cells, which demonstrated that Nrf2 expression shared an inverse relationship with 11β-Hsd1,
with an increase in the latter resulting in an impaired cellular oxidant neutralization response.
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The observed elevation in circulating corticosterone at both stress time-points was accompanied
by a down-regulation of GR (Nr3c1) and CBG (Serpina6) following 3 days of repeated acute stress.
Fluctuations in CBG levels can directly affect glucocorticoid bioavailability through its property as
a high-affinity corticosteroid-binding protein. Previous studies demonstrated down-regulation in
CBG expression increases the free (unbound) fraction of glucocorticoids following both acute and
chronic stressors [7,8]. This down-regulation is regulated by glucocorticoids at a transcriptional
level via the GR which leads to C/EBPβ recruitment to the Cbg promoter [30]. The availability of
tissue glucocorticoids is also governed via intracellular metabolism by 11β-HSDs. Although it was
reported that 11β-Hsd1 can possess bidirectional enzymatic activity, the increase in its expression
in vivo is believed to function as a reductase to generate active glucocorticoid, thus enhancing GR
activation [31,32]. While 11β-Hsd2 acts exclusively as a dehydrogenase, the observed reduction in
the present study following both stress time-points suggests there is reduced capacity to deactivate
corticosterone [33]. Taken together, increased total circulating corticosterone and increased expression
of 11β-Hsd1 with reduced expression of 11β-Hsd2 and CBG suggest that local hepatic tissues experience
high levels of bioactive glucocorticoid resulting in GR down-regulation following stress.
As the end product of the HPA axis, glucocorticoids regulate multiple aspects of energy metabolism
in the adaptive response to stress, including hepatic gluconeogenesis [34]. However, during the course
of energy production, stress-induced glucocorticoids have been shown to be a causative factor of
oxidative stress, inflammation, and damage within the liver [35]. Consistent with this observation,
we showed a decrease in GSH and an increase in the product of GSH oxidation (GSSG), following
1 and 3 days of restraint stress, indicative of hepatic oxidative stress. There was also a sustained
stress-induced decrease in free cysteine thiols, the immediate precursor of GSH, which further suggests
an altered glutathione redox balance. Interestingly, the delayed increase in oxidized GSSG despite
significant reductions in GSH and cysteine thiols suggests that GSSG formation may be secondary
to other reactions that remove GSH from the measurable thiol pool. A likely candidate would be
S-glutathionylation, a post-translational protein modification that was shown to increase in response to
oxidative stress in primary rat hepatocytes and is involved in approximately 10% of 4-HNE disposition
in the rat liver [36,37]. Additionally, Yu and Long [38] demonstrated that cysteine is the primary amino
acid regulating cellular GSH homeostasis using hepatocellular carcinoma cells. Prior studies also
demonstrated that a deficiency in intracellular cysteine can trigger a unique iron-dependent form
of nonapoptotic cell death, termed ferroptosis, primarily due to failure in synthesizing GSH [39,40].
The expression profile of other antioxidant enzymes including Cu, Zn-SOD and mitochondrial Mn-SOD
were also examined, with both becoming up-regulated following 6 hours of restraint, while hepatic
catalase was down-regulated following 3 days of acute repeated stress. This is in agreement with a
previous study employing longer stress durations where both immobilization and cold stress led to
increased Cu, Zn-SOD and decreased catalase activities in the rat liver [41].
Further evidence that stress treatment induced liver redox imbalance were the increases in the
general oxidative status, markers of lipid peroxidation, and protein oxidation in the liver of rats
subjected to restraint stress. In agreement with the present study, Rajaraman and colleagues [42]
showed that treatment with the synthetic glucocorticoid, dexamethasone, significantly increased DCF
fluorescence together with higher lactate dehydrogenase release, indicating a general increase in
reactive oxygen species and hepatocellular damage. As one of the mechanisms of stress-induced
liver injury, lipid peroxidation was examined in the present study by both MDA formation
and immunohistochemical staining for 4-HNE. Studies demonstrated that accumulation of lipid
hydroperoxides induces ferroptosis driven by GSH depletion and/or loss of lipid-protective GPx4
enzyme activity [40,43]. Dodson and colleagues [44] provided further evidence that Nrf2 plays a
pivotal role in preventing this process by transcriptionally regulating anti-ferroptotic and antioxidant
genes, which equilibrates iron/heme metabolism and reduces lipid peroxidation. Furthermore, we
also observed an increased level of carbonylated proteins following 3 days of acute repeated stress.
Previous studies demonstrated similar increases in hepatic protein oxidation following physiological
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stress employing acute exhaustive exercise [45,46]. In addition to protein carbonylation, we examined
the effects of acute repeated stress on another form of post-translational protein modification caused
by higher concentrations of nitrating species. The increase in 3-NT following 3 days of repeated stress
represents a footprint of peroxynitrite formation and increased mitochondrial superoxide formation.
Interestingly, Zhu and colleagues [47] demonstrated that Cu, Zn-SOD activity is crucial for the catalysis
of hepatic protein nitration in murine models of metabolic stress. It is well established that hepatotoxic
agents including lipopolysaccharide and acetaminophen induce excessive tyrosine-nitrated proteins
accompanied by a marked up-regulation of inducible nitric oxide synthase expression [48–51]. In our
stress model, we showed that there was also an up-regulation of inducible and endothelial NOS
following a single episode of stress. Similar effects were observed in our previous studies in the
central nervous system [52,53]. Zhang and colleagues [54] reported that the inducible NOS inhibitor,
L-iminoethyl-lysine, reverses metabolic stress-induced GSH depletion, lipid peroxidation, and 4-HNE
accumulation in the rat liver. Conversely, using a human NOS3 adenoviral vector, overexpression
of endothelial NOS increased levels of nitrotyrosine, markers of liver injury, and apoptosis in mice
following ischemia/reperfusion [55]. The authors also suggested that the observed liver injury was likely
due to NO-induced inhibition of mitochondrial respiration in the endothelial NOS-overexpressing
mice. Together, these studies suggest that both the inducible and endothelial form of NOS are capable
of producing excessive NO to cause the observed peroxynitrite-mediated 3-NT and 4-HNE formation.
Despite the observed stress-induced oxidative and nitrosative stress in the liver, the expression
of transcription factor Nrf2 was robustly down-regulated. Immunofluorescence analysis revealed
that Nrf2 was shuttled into the nucleus following 1 day of stress exposure, whereas no nuclear Nrf2
signal was observed at day 3. Nuclear Nrf2 is likely redirected from a pool of existing Nrf2 protein
and may be responsible for the observed transient up-regulation of antioxidant enzymes, including
Sod isoforms and Gpx4. Numerous studies previously demonstrated that covalent modification of
Nrf2 by phosphorylation/dephosphorylation and acetylation/deacetylation modulates Nrf2 nuclear
translocation/export and degradation [56,57]. The compelling observation of Nrf2 down-regulation
in hepatic tissues was also demonstrated in a previous in vitro study [27]. Using HEK-293 cells,
Kratschmar and colleagues [27] demonstrated that activation of GR under physiological concentrations
of glucocorticoids significantly suppressed Nrf2 transactivation capacity. Furthermore, Nrf2 activity
was reduced following cortisol or cortisone incubation in H4IIE cells transiently transfected with rat
11β-Hsd1, with either GR antagonist or 11β-Hsd1 inhibitor reversing this glucocorticoid-dependent
inhibition. It was suggested that recruitment of corepressors including silencing mediator for retinoid
and thyroid hormone receptors (SMRTs) and nuclear receptor corepressor (N-CoRs) may be responsible
for this GR-steroid complex-mediated Nrf2 repression [58]. Conversely, although expression of the
related transcription factor, Nrf1, showed a modest up-regulation following acute stress, this minor
change is unlikely to translate into a biologically relevant response. The observed down-regulation of
Nrf2 does not seem to be associated with the Keap1 repressor at the transcriptional level. However,
accumulating studies have now demonstrated alternative, Keap1-independent mechanisms of Nrf2
regulation, including phosphorylation of Nrf2 by protein kinases, interactions with other protein
partners, and epigenetic factors [59–61]. The expression of Gclc, one of the primary Nrf2-controlled
antioxidant enzymes, was down-regulated at both time-points examined. As a rate-limiting catalyst in
the first step of GSH biosynthesis, the down-regulation of Gclc indicates that there is potentially no
compensation for the loss in GSH observed in the present study. Previous work observed similar effects
where transcripts encoding both subunits of glutamate-cysteine ligase were robustly reduced in Nrf2
knockout fibroblasts and liver tissues [62]. Furthermore, we observed that Gpx4 was paradoxically
increased following a single episode of restraint stress. It was well documented that Gpx4 is essential
to reduce lipid peroxides and acts as a central endogenous suppressor of ferroptosis [63–65]. While the
observed up-regulation in hepatic Gpx4 expression may offer some cellular protection, the induction is
transient, relatively low, and does not offset the loss of GSH or accumulation of 3-NT and 4-HNE.
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The expression of two other ARE-regulated phase II detoxifying enzymes, Hmox1 and Nqo1,
was strongly up-regulated in the liver following 1 and 3 days of restraint stress. Although both
enzymes were been shown to be regulated by Nrf2, several studies reported alternative regulation
by transcription factor Foxo1 which specifically induces Hmox1 gene transcription by direct DNA
binding, independent of Nrf2 [66–68]. Wang and colleagues [69] further demonstrated that protein
expression of both Hmox1 and Nqo1 were significantly up-regulated in Foxo1-overexpressing murine
cells and attenuated high glucose-induced oxidative stress. The observed up-regulation in Foxo1
expression in the present study may be an important alternative factor driving antioxidant gene
transcription during a state of GR-steroid complex-mediated Nrf2 repression. Furthermore, emerging
studies on the epigenetic regulator Brd4 showed a modulatory role on the Nrf2-Keap1-ARE signaling
pathway [70–72]. Although the minor change in Brd4 suggests this is not biologically relevant to stress
regulation in the liver, knockdown of Brd4 was previously shown to robustly down-regulate both
Hmox1 gene and protein expression in HEK293T cells [70]. Together, these findings provide insights
into the alternative transcriptional regulatory network of the cellular response to stress-induced hepatic
oxidative stress.
Stress-induced oxidative stress appears to generate a tissue specific response that in the liver,
is characterized by a robust and antithetical reduction in the Nrf2-Keap1-ARE signaling pathway.
This results in substantial reductions in GSH/cysteine thiol-mediated cellular antioxidant capacity and
increased oxidative damage to lipids and proteins. Moreover, despite high levels of circulating
glucocorticoids, local hepatic tissue levels of corticosterone are likely potentiated further by a
systematic increased in bioavailability mediated by reduced protein binding and increased reactivation.
Our findings indicate that the liver displays an unusual physiological response to restraint stress that
appears to exacerbate oxidative stress likely by impairing the canonical Nrf2-Keap1-ARE signaling
pathway and the tissue’s antioxidant capacity.
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